2026· International Journal of Environment and Health Sciences· 0 citations· 20 references
TL;DR
This study reviews the sources, fate, and impacts of pharmaceutical contaminants, emphasizing both conventional and modern drugs, including expired medications, and highlights the challenges associated with inadequate regulatory frameworks, limited public awareness, and inefficiencies in existing treatment technologies.
Abstract
Pharmaceutical pollutants have emerged as a critical environmental and public health concern due to their continuous release into ecosystems through manufacturing effluents, improper disposal of expired drugs, hospital waste, and incomplete removal during wastewater treatment. These drug residues persist in water, soil, and biota, causing ecological imbalance, development of antimicrobial resistance, endocrine disruption, and potential long-term toxicity in humans. The life-cycle of pharmaceuticals, from production and consumption to disposal, plays a significant role in determining their environmental footprint. This study reviews the sources, fate, and impacts of pharmaceutical contaminants, emphasizing both conventional and modern drugs, including expired medications. It highlights the challenges associated with inadequate regulatory frameworks, limited public awareness, and inefficiencies in existing treatment technologies. Furthermore, the manuscript discusses the toxicological effects of drug pollutants on aquatic organisms and humans, stressing the need for integrated waste management and green pharmaceutical practices. Emphasis is placed on safety precautions such as proper drug disposal programs, advanced wastewater treatment methods, eco-pharmacovigilance, and the development of environmentally benign drugs. The study underscores the importance of sustainable strategies to minimize pharmaceutical pollution and protect ecosystem integrity and human health. Overall, this work contributes to a better understanding of pharmaceutical life-cycle impacts and provides a foundation for policy formulation and future research aimed at achieving environmental sustainability in healthcare systems.
The improper disposal of expired and unused pharmaceutical products has become something
of great public health and environmental concern worldwide. This study examines the
pathways through which pharmaceuticals enter the environment, including household waste,
sewage systems, and landfill leachates, and assess thei...
Yinka Akinade· International Journal of Hea...· 0 citations
This review summarizes the existing evidence on pharmaceutical contaminants in Indian freshwaters with the focus on classes of pollutants, sources of contamination, environmental fate, toxicological pathways, ecological risks and remediation strategies.
Vineet Kumar Poddar, A. Kumar, Ayan Srivastava et al.· Environmental Toxicology· 0 citations
Pharmaceuticals and personal care products (PPCPs) have emerged as contaminants of increasing environmental concern due to their continuous release, widespread occurrence, and persistence in aquatic ecosystems. Although numerous studies have investigated their occurrence, transformation, and removal, a comprehensive sy...
A. Bhat, A. Chaudhary, Mohamed A. M. Ali et al.· Marine Pollution Bulletin· 0 citations
A comparative analysis of environmental risk assessment methods used in the European Union, United States, and Russia is conducted to conduct a comparative analysis of modern approaches to assessing the impact of drugs on the environment in various regulatory systems.
A. V. Golovin, N. Pyatigorskaya, S. А. Loseva et al.· Drug development & regis...· 0 citations
Emerging contaminants (ECs) comprise a diverse group of synthetic and naturally occurring chemicals that are not routinely monitored but are increasingly recognized for their potential risks to ecosystems and human health. Many ECs, such as pharmaceuticals, personal care products, endocrine-disrupting compounds, pest...
A. Ismanto, Tony Hadibarata, Lilik Maslukah et al.· Environmental Sustainability· 0 citations
The synthesis indicates that no single biological technology provides universal control and risk reduction is more defensibly pursued through source control, robust biological treatment and targeted polishing, supported by mass balances, transformation-product screening, effect-based endpoints and antimicrobial-resista...
Yogita Basene, Shreeti Shrivastawa· Asian Journal of Environment...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.